137 related articles for article (PubMed ID: 2914298)
21. [Recent aspects in the diagnosis and therapy of ascites].
Gerbes AL
Z Gastroenterol; 1987 Oct; 25(10):677-82. PubMed ID: 3318185
[TBL] [Abstract][Full Text] [Related]
22. Fibronectin concentration in ascites does not differentiate between malignant and nonmalignant ascites.
Villar M; Garcia-Bragado F; Vilardell M; Biosca M; Rodrigo MJ; Schwartz S
Gastroenterology; 1988 Feb; 94(2):556-7. PubMed ID: 3335331
[No Abstract] [Full Text] [Related]
23. Value of ascitic fibronectin and cholesterol concentration in the differentiation between malignancy-related and non-malignant ascites.
Archimandritis A; Kapsalas D; Douvara M; Tjivras M; Tsirantonaki M; Fertakis A
Ann Med Interne (Paris); 1996; 147(3):145-50. PubMed ID: 8796090
[TBL] [Abstract][Full Text] [Related]
24. Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy.
Colloredo Mels G; Bellati G; Auriemma L; Perani C; Leandro G; Vacca N; Pinna N; Alfieri G; Ideo G
Ital J Gastroenterol; 1991 May; 23(4):179-86. PubMed ID: 1661195
[TBL] [Abstract][Full Text] [Related]
25. C-reactive protein and insulin-like growth factor-1 in differential diagnosis of ascites.
Abdel-Razik A; Eldars W; Elhelaly R; Elzehery R
J Gastroenterol Hepatol; 2016 Nov; 31(11):1868-1873. PubMed ID: 27010362
[TBL] [Abstract][Full Text] [Related]
26. Measurement of fibronectin concentration in benign and malignant ascites.
Adamsen S; Jönsson P; Brodin B; Lindberg B; Jorpes P
Eur J Surg; 1991 May; 157(5):325-8. PubMed ID: 1678645
[TBL] [Abstract][Full Text] [Related]
27. Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.
Castaldo G; Oriani G; Cimino L; Topa M; Mostarda I; Castellano L; Del Vecchio-Blanco C; Budillon G; Salvatore F; Sacchetti L
Clin Chem; 1994 Mar; 40(3):478-83. PubMed ID: 8131285
[TBL] [Abstract][Full Text] [Related]
28. Determination of the optimal volume of ascitic fluid for the precise diagnosis of malignant ascites.
Zhang F; Feng Z; Zhang Y; Liu Z; Sun X; Jin S
Saudi J Gastroenterol; 2019; 25(5):327-332. PubMed ID: 30900607
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic paracentesis. A two-step approach.
Sartori M; Andorno S; Gambaro M; Leone F; Molinari GL; Pontiroli L; Aglietta M
Ital J Gastroenterol; 1996; 28(2):81-5. PubMed ID: 8781999
[TBL] [Abstract][Full Text] [Related]
30. Laminin concentration in ascites of patients with hepatic cirrhosis and peritoneal carcinomatosis.
Catarino RM; Lopes JD; Forones NM; Parise ER
Braz J Med Biol Res; 2005 Feb; 38(2):271-6. PubMed ID: 15785839
[TBL] [Abstract][Full Text] [Related]
31. Ascitic fluid cholesterol in malignant and tubercular ascites.
Sood A; Garg R; Kumar R; Chhina RS; Arora S; Gupta R; Bhatia KL
J Assoc Physicians India; 1995 Nov; 43(11):745-7. PubMed ID: 8773030
[TBL] [Abstract][Full Text] [Related]
32. [Concentration of lipids in ascitic fluid and the concentration gradient of albumin in blood and ascites: diagnostic significance].
Barbare JC; Diab G; Delavenne J; Philippe JM; Vorhauer W; Latrive JP; Capron JP
Ann Gastroenterol Hepatol (Paris); 1989 Nov; 25(6):251-6. PubMed ID: 2619252
[TBL] [Abstract][Full Text] [Related]
33. Human chorionic gonadotropin-beta in the differentiation of malignancy-related and nonmalignant ascites.
Gerbes AL; Hoermann R; Mann K; Jüngst D
Digestion; 1996; 57(2):113-7. PubMed ID: 8786000
[TBL] [Abstract][Full Text] [Related]
34. Ascites in the state of Qatar: aetiology and diagnostic value of ascitic fluid analysis.
Khan FY
Singapore Med J; 2007 May; 48(5):434-9. PubMed ID: 17453102
[TBL] [Abstract][Full Text] [Related]
35. Development and validation a simple model for identify malignant ascites.
Guo YY; Peng XL; Zhan N; Tian S; Li J; Dong WG
Int J Med Sci; 2021; 18(9):1966-1974. PubMed ID: 33850466
[TBL] [Abstract][Full Text] [Related]
36. Peritoneoscopy in diagnosis of ascites.
Amarapurkar DN; Kalro RH; Desai HG
J Assoc Physicians India; 1991 Dec; 39(12):933-5. PubMed ID: 1840061
[TBL] [Abstract][Full Text] [Related]
37. Serum-ascites albumin concentration gradient and ascites fibronectin in the diagnosis of malignant ascites.
Lee CM; Changchien CS; Shyu WC; Liaw YF
Cancer; 1992 Oct; 70(8):2057-60. PubMed ID: 1394035
[TBL] [Abstract][Full Text] [Related]
38. [Value of ascitic lipids and sero-ascitic gradient of albumin in the differential diagnosis of ascites].
Cabral JE; Leitão MC; Guerra C; Tomé L; Pinto ML; Costa D; Monteiro G
Acta Med Port; 1989; 2(1):17-20. PubMed ID: 2773676
[TBL] [Abstract][Full Text] [Related]
39. [Ascites. Diagnostic orientation and management].
Diaz D; Michel H
Rev Prat; 1990 Apr; 40(10):938-40. PubMed ID: 2326581
[No Abstract] [Full Text] [Related]
40. Value of ascitic lipids in the differentiation between cirrhotic and malignant ascites.
Jüngst D; Gerbes AL; Martin R; Paumgartner G
Hepatology; 1986; 6(2):239-43. PubMed ID: 3957233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
